Wordt geladen...
Adverse Events following Cancer Immunotherapy: Obstacles and Opportunities
Oncology has recently undergone a revolutionary change with widespread adoption of immunotherapy for many cancers. Immunotherapy using monoclonal antibodies against “checkpoint” molecules, including PD-1, PD-L1, and CTLA-4, is highly effective in a significant subset of patients. However, immune-rel...
Bewaard in:
| Gepubliceerd in: | Trends Immunol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527345/ https://ncbi.nlm.nih.gov/pubmed/31053497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.it.2019.04.002 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|